
Labcorp, Quest, and ARUP Develop Bird Flu Tests with CDC Help
The assays were developed with the CDC as part of recent trend of public-private partnerships to improve pandemic preparedness
The assays were developed with the CDC as part of recent trend of public-private partnerships to improve pandemic preparedness
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow
The roughly $1 billion deal will boost the company’s annual revenue by about 7 percent, and will give Quest a stronger presence in Canada
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains